Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis
Hyo Young Lee, Dae Won Jun, Hyun Jung Kim, Hyunwoo Oh, Waqar Khalid Saeed, Hyeongsik Ahn, Ramsey C. Cheung, Mindie H. Nguyen
Korean J Intern Med. 2019;34(2):296-304.   Published online 2018 Mar 20     DOI: https://doi.org/10.3904/kjim.2017.194
Citations to this article as recorded by Crossref logo
The utility of ezetimibe therapy in nonalcoholic fatty liver disease
Baek Gyu Jun, Gab Jin Cheon
The Korean Journal of Internal Medicine.2019; 34(2): 284.     CrossRef
Lipids: a personal view of the past decade
Niki Katsiki, Dimitri P Mikhailidis
Hormones.2018; 17(4): 461.     CrossRef
Soybean Oil-Derived Poly-Unsaturated Fatty Acids Enhance Liver Damage in NAFLD Induced by Dietary Cholesterol
Janin Henkel, Eugenia Alfine, Juliana Saín, Korinna Jöhrens, Daniela Weber, José Castro, Jeannette König, Christin Stuhlmann, Madita Vahrenbrink, Wenke Jonas, André Kleinridders, Gerhard Püschel
Nutrients.2018; 10(9): 1326.     CrossRef